Investments In AIoT And Medical Services Will Boost Future Profitability

Published
21 Feb 25
Updated
08 Aug 25
AnalystConsensusTarget's Fair Value
NT$28.50
2.8% undervalued intrinsic discount
08 Aug
NT$27.70
Loading
1Y
-16.4%
7D
2.4%

Author's Valuation

NT$28.5

2.8% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 30%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 1.41%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 0.32%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on13 Mar 25
Fair value Increased 42%

AnalystConsensusTarget has decreased revenue growth from 6.6% to 5.1%, decreased profit margin from 3.6% to 2.3% and increased future PE multiple from 12.0x to 18.1x.